# Sutro Biopharma, Inc.: Form DEF 14A, filed Apr 25, 2022

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: DEF 14A
- Filed: 2022-04-25
- Accepted by EDGAR: Apr 22, 2022, 19:55 ET
- Period: 2022-06-06
- Accession: 0000950170-22-006031
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000095017022006031/stro-def14a-2022.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000095017022006031/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000095017022006031/stro-def14a-2022.htm

Filed Apr 25, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-006031. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.